Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioadaptives (BDPT) Inventory Average (2019 - 2025)

Bioadaptives' Inventory Average history spans 7 years, with the latest figure at $41901.0 for Q3 2025.

  • For Q3 2025, Inventory Average changed N/A year-over-year to $41901.0; the TTM value through Sep 2025 reached $41901.0, changed N/A, while the annual FY2024 figure was $17198.0, 42.38% up from the prior year.
  • Inventory Average for Q3 2025 was $41901.0 at Bioadaptives, up from $40079.0 in the prior quarter.
  • Across five years, Inventory Average topped out at $41901.0 in Q3 2025 and bottomed at $4161.0 in Q1 2022.
  • The 5-year median for Inventory Average is $10149.0 (2021), against an average of $14264.9.
  • The largest annual shift saw Inventory Average plummeted 68.12% in 2022 before it surged 226.22% in 2025.
  • A 5-year view of Inventory Average shows it stood at $7175.5 in 2021, then grew by 17.6% to $8438.5 in 2022, then skyrocketed by 33.5% to $11265.5 in 2023, then rose by 9.06% to $12286.0 in 2024, then surged by 241.05% to $41901.0 in 2025.
  • Per Business Quant, the three most recent readings for BDPT's Inventory Average are $41901.0 (Q3 2025), $40079.0 (Q2 2025), and $29849.5 (Q1 2025).